Physician profile
Gloria Ong
NPI 1134570971
$6,116.14
in general payments reported to CMS, 2019-2025
42 companies · $432 in 2025
The $432 reported for 2025 was more than what a typical Internal Medicine provider received nationally (typical 2025 total: $156).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $281 · 2020: $1,297 · 2021: $1,315 · 2022: $1,128 · 2023: $633 · 2024: $1,030 · 2025: $432.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,095.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,094.99 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novo Nordisk INC | $1,176.96 | 2020-2025 | Rybelsus, Ozempic, Wegovy |
| Glaxosmithkline, LLC. | $823.55 | 2019-2024 | Trelegy Ellipta, Shingrix |
| Astrazeneca Pharmaceuticals Lp | $449.72 | 2019-2025 | Breztri, Farxiga |
| Pfizer INC. | $447.28 | 2019-2025 | |
| Abbott Laboratories | $404.51 | 2021-2025 | Freestyle Libre 3, Eterna, Mitraclip |
| Janssen Pharmaceuticals, INC | $307.05 | 2019-2024 | Xarelto |
| Astellas Pharma US INC | $288.03 | 2019-2025 | Veozah |
| Boehringer Ingelheim Pharmaceuticals, INC. | $273.80 | 2020-2025 | Jardiance, Synjardy, Jascayd |
| Abbvie INC. | $242.59 | 2021-2025 | |
| Sanofi-Aventis U.S. LLC | $201.09 | 2020-2025 | |
| Lilly USA, LLC | $125.39 | 2020-2025 | Mounjaro, Trulicity, Kisunla |
| Medtronic, INC. | $121.07 | 2021-2025 | Symplicity G3, Linq II |
| Amarin Pharma, INC. | $108.46 | 2020-2021 | |
| Biosense Webster, INC. | $103.05 | 2024 | Na |
| Intuitive Surgical, INC. | $99.49 | 2023 | Da Vinci Surgical System |
Show all 42 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Gloria Ong listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.